Phase II Trial of Leronlimab for COVID-19 Enrolls First Patients

0
220

[ad_1]

Phase II Trial of Leronlimab for COVID-19 Enrolls First Patients 1
CytoDyn announced that it has enrolled and treated the first 2 patients with COVID-19 with leronlimab under its phase II randomized clinical trial.

[ad_2]